Comparative immunity of Salmo salar and Oncorhynchus kisutch during infestation with the sea louse Caligus rogercresseyi: An enrichment transcriptome analysis.

Caligus rogercresseyi, an ectoparasite affecting the Chilean salmon industry, can cause immunosuppression and physiological stress in farmed fish. Interestingly, coho salmon (Oncorhynchus kisutch) are notably resistant to infestation, whereas Atlantic salmon (Salmo salar) are phenotypically more susceptible to sea lice. However, comparative studies on immune responses to C. rogercresseyi have not been conducted. In this study, Illumina sequencing was conducted to evaluate head kidney and skin samples taken 7 and 14 days post-infestation, yielding a total of 1492 and 1522 contigs annotated to immune-related genes for Atlantic and coho salmon, respectively. Both species evidenced an upregulation of inflammatory genes. Atlantic salmon had highly upregulated TLR22 and MHCII at 14 days post-infestation, while coho salmon had highly upregulated stat5 and il1r transcripts. Fourteen transcripts related to TH1, TH2, TLR, and macrophage responses were corroborated via RT-qPCR. Statistical analyses indicated an upregulation of mmp13, cox2, il10, ccr3, tlr22a2, and tlr21 in Atlantic salmon and of ifnγ, cd83, T-bet, tlr13, and tlr19 in coho salmon. These results suggest strong differences between the Atlantic and coho salmon immune responses, where coho salmon, the more resistant species, presented a primary TH1 response. Additionally, putative roles of TLRs in salmonids against sea lice were evidenced. This study is the first comparative transcriptome analysis that reveals species-specific immune responses in salmons infected with C. rogercresseyi.

Basophils and allergic inflammation.

Basophils were discovered by Paul Ehrlich in 1879 and represent the least abundant granulocyte population in mammals. The relative rarity of basophils and their phenotypic similarities with mast cells resulted in this cell lineage being historically overlooked, both clinically and experimentally. However, recent studies in human subjects and murine systems have shown that basophils perform nonredundant effector functions and significantly contribute to the development and progression of TH2 cytokine-mediated inflammation. Although the potential functions of murine and human basophils have provoked some controversy, recent genetic approaches indicate that basophils can migrate into lymphoid tissues and, in some circumstances, cooperate with other immune cells to promote optimal TH2 cytokine responses in vivo. This article provides a brief historical perspective on basophil-related research and discusses recent studies that have identified previously unappreciated molecules and pathways that regulate basophil development, activation, and function in the context of allergic inflammation. Furthermore, we highlight the unique effector functions of basophils and discuss their contributions to the development and pathogenesis of allergic inflammation in human disease. Finally, we discuss the therapeutic potential of targeting basophils in preventing or alleviating the development and progression of allergic inflammation.

Alteración de la actividad inflamatoria regulada por T H1-T H2 en asma / Alteration of the inflammatory activity regulated by T H1-T H2 en asthma

El asma afecta entre 100 y 150 millones de personas en el mundo. En la actualidad, esta enfermedad se puede controlar por diversas terapias, pero no se puede curar y representa una de las enfermedades más costosas y frecuentes en los sistemas de salud en muchos países, por lo que son necesarias estrategias de prevención eficientes para reducir la morbimortalidad y costos económicos; esto requiere, entre otros, de un conocimiento detallado de los mecanismos inmunológicos y fisiológicos involucrados en el asma. Esta revisión sintetiza el conocimiento sobre la inflamación mediada por T H2 en asma y se discute el origen d elas células CD4+ T H'2 y el papel de las citocinas T H2 en la producción y mantenimiento de la inflamación de las vías respiratorias en esta enfermedad.

Asthma affects between 100 and 150 million people around the globe. Currently, it is a disease that can be controlled by diverse therapeutic approaches; unfortunately, it cannot be cured. In many countries asthma is one of the most expensive and frequent diseases for the healthcare systems. Therefore, effective preventive strategies are greatly needed to reduce individual morbidity, mortality and economic burdens. This requires, among others, a detailed knowledge of the immunoiogicai and physiological mechanisms involved in asthma. This review synthesizes our understanding about the inflammation of T H2-mediated asthma and discusses the origin of CD4 + T H2 cells and the role of T H2 cytokines in producing and maintaining airway inflammation in asthma.